By preventing troublesome crosslinking, breakthrough gelatin technology is enabling pharmaceutical and supplement manufacturers to guarantee the stability of softgels destined for the Asia-Pacific market.
Softgel capsules are set for rapid growth in the next five years, with Asia-Pacific leading the way. The region’s softgel market is projected to expand by 6.6% year on year between now and 2027, and for countries such as India and China, even stronger growth is forecast1.